IFNG and cancer: Preliminary studies have found that activation of cell signaling pathways such as the interferon-gamma (IFNγ) pathway confers resistance to ICB, however the underlying mechanisms of unresponsiveness to ICB in various types of cancers are still poorly understood (203).